Key statistics
On Wednesday, Alterity Therapeutics Ltd (ATHE:NAQ) closed at 3.53, 40.03% above the 52 week low of 2.52 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.52 |
|---|---|
| High | 3.55 |
| Low | 3.43 |
| Bid | 3.40 |
| Offer | 3.69 |
| Previous close | 3.48 |
| Average volume | 13.44k |
|---|---|
| Shares outstanding | 18.13m |
| Free float | 7.54m |
| P/E (TTM) | -- |
| Market cap | 61.55m USD |
| EPS (TTM) | -0.8701 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 20:59 GMT.
More ▼
Announcements
- Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
- Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026
- Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
- Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
- Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
- Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
- Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
- Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
- Alterity Therapeutics Raises A$20.0 million in Strategic Placement
- Alterity Therapeutics to Present at the Biotech Showcase
More ▼
